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ABSTRACT 
Hiday, Andrew C. M.S., Purdue University, May 2015. Phosphorylation State Modulates 
the Interaction between Neurofilament Medium and Spinophilin. Major Professor: A.J. 
Baucum. 
 
 
A histological marker of Parkinson’s disease (PD) is the loss of synapses located 
on striatal medium spiny neurons (MSNs) as a result of dopaminergic nigral cell 
depletion. The dendritic spines that give MSNs their name have a well-characterized 
structure and are the main regions of post-synaptic input. It has been shown that spines 
have altered functionality and morphology in many neurodegenerative diseases. Spine 
morphology, and potentially function, is dictated by an array of structural proteins and 
their associations with other proteins in a region dubbed the post-synaptic density (PSD). 
Spinophilin and neurofilament medium (NF-M) are two proteins that are enriched in the 
PSD and have potential implications in PD. Interestingly, preliminary data show that 
there is a decrease in the NF-M-spinophilin interaction in animal models of PD. Here it is 
shown that these two proteins interact in brain tissue and when overexpressed in a 
mammalian cell system. Moreover, we have begun to determine mechanisms that 
regulate this interaction. 
It is known that there is a misregulation of protein phosphatases and kinases in 
many neurodegenerative diseases. Moreover, the phosphorylation state of a protein can
 
 
xi 
 
regulate its association with other proteins. Therefore, we hypothesize that the 
phosphorylation state of either protein affects the interaction between spinophilin and 
NF-M. Furthermore, we have conducted experiments utilizing protein phosphatases and 
kinases that are known to modulate the phosphorylation state of NF-M and/or 
spinophilin. Data show that both kinase and phosphatase activity and/or expression 
modulates the NF-M-spinophilin interaction in heterologous cell lines. Through the use 
of MS/MS analysis, we have begun to map specific phosphorylation sites that may play a 
role in regulating this interaction. Currently, we are elucidating the specific effects of 
these post-translational modifications on regulating the spinophilin-NF-M interaction. 
These data will enhance our knowledge of spinophilin’s interactions and how these 
interactions are altered in neurological disorders such as PD.  
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CHAPTER 1. INTRODUCTION 
1.1 Parkinson’s Disease History and Pathology 
Parkinson’s disease (PD) is a progressive neurodegenerative disease that was first 
described nearly two centuries ago. In his essay, James Parkinson described the hallmark 
presentations of PD or the “shaking palsy”: resting tremor, postural and gait instability, 
and hypokinesia (Parkinson 1817). Although Parkinson and others began describing the 
clinical presentations of PD in the early 19th century, it was not until the early 20th 
century that Friedrich Lewy first began to characterize the major histopathological 
markers of the disease, which was then known as paralysis agitans (Lewy 1912). We now 
know that these structures, commonly referred to as Lewy Bodies, contain α-synuclein 
aggregates that disrupt normal cell function, eventually resulting in the death of 
presynaptic cells (Spillantini et al. 1997).  
PD most greatly affects the substantia nigra, leading to a loss of pigment and 
severe atrophy therein. When approximately 80% of these neurons have been lost, motor 
deficits discussed above begin to be observed (Rodriguez-Oroz et al. 2009). The sporadic 
form of the disease is most common. While the underlying mechanisms linked to this 
sporadic form are unclear, gene-gene interactions, environmental factors, and gene-
environmental interactions play a role. Familial or genetic forms also exist. Common 
mutations found in familial PD include those in the SNCA (synuclein) and LRRK2 
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(leucine-rich repeat kinase 2) genes among others (Polymeropoulos et al. 1997; Lesage et 
al. 2006). Typically, these mutations lead to improper protein aggregation and/or protein 
clearance resulting in formation of the aforementioned Lewy bodies and subsequent cell 
death (Gibb and Lees 1988; Spillantini et al. 1997).  
Currently, there are several treatments for PD, none of which treat its underlying 
cause (loss of dopamine-releasing nigrostriatal neurons). Of these drugs, L-DOPA 
therapy is the oldest and most widely used. As will be discussed more in-depth below, 
one of the markers of PD is striatal dopamine (DA) depletion. L-DOPA is a DA precursor 
that can help mitigate this loss (Dauer and Przedborski 2003). In PD patients, L-DOPA is 
converted to DA, thereby attenuating many of the motor symptoms associated with the 
disease (Hornykiewicz 1974). However, long-term L-DOPA treatment is associated with 
debilitating side effects and waning efficacy. In human PD patients as well as non-human 
primates and rats, L-DOPA eventually leads to an increase in involuntary movements 
called dyskinesias (Pearce et al. 1995; Cenci et al. 1998). A more recent treatment of the 
disease includes deep-brain stimulation (DBS) of the subthalamic nucleus or the globus 
pallidus. In patients receiving this treatment, electrodes are implanted directly into the 
specific brain region where pulses are emitted at an appropriate frequency. This has 
proven very effective in decreasing the severity of PD motor symptoms (Kumar et al. 
1998; Deep-Brain Stimulation for Parkinson's Disease Study Group 2001). However, 
both of these types of treatments, among others, only treat the symptoms of the disease. 
Treating the underlying causes of the disease has proven much more difficult (Shulman et 
al. 2011). 
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1.2 Brain Function and Parkinson’s Disease 
Normal brain function requires connectivity between different brain regions. This 
connectivity is achieved through the projection of axons from one brain region creating 
connections (synapses) in a second region (Sheng and Hoogenraad 2007). For instance, 
excitatory, glutamatergic neurons in the cortex project to, and synapse on, dendritic 
spines located on striatal medium spiny neurons (MSNs). Additionally, dopamine-
containing neurons that reside in the substantia nigra also project to, and synapse on, 
these dendritic spines (Björklund and Lindvall 1975). This tripartite synapse (Figure 1; 
Sheng and Hoogenraad 2007) is the site of altered synaptic connectivity in PD, the 
second most common neurodegenerative disease. Specifically, there is a loss of nigral 
dopaminergic projections leading to downstream consequences in the dendritic spines of 
striatal MSNs (German et al. 1989). These downstream consequences include modulation 
of normal PKA signaling in these MSNs (Nishi et al., (2008). 
Glutamate release from the presynaptic nerve terminal activates glutamate 
receptors such as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors 
(AMPARs) and N-methyl-D-aspartate receptors (NMDARs) on the postsynaptic 
dendritic spine (Hering and Sheng 2001). These dendritic spines, first described by 
Ramón y Cajal over a century ago, have a well-characterized structure and serve as the 
main site of postsynaptic input through a significant increase in overall dendrite surface 
area (Ramón y Cajal 1888; Gray 1959). Moreover, the relative number and morphology 
of spines is directly related to synaptic activity. For example, spines with a thinner, 
filopodial-like structure tend to correlate with decreased synaptic activity compared to 
spines with larger, mushroom-like shapes (Hering and Sheng 2001). Following glutamate 
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stimulation of postsynaptic receptors and depolarization of the postsynaptic neuron, there 
is an influx of calcium and other ions that serve as activators of signal transduction 
pathways. This occurs at the tip of the dendritic spine in a region dubbed the postsynaptic 
density (PSD) (Häusser et al. 2000). Additionally, it is believed that the overstimulation 
of glutamate receptors might be responsible for loss of receptor function in disorders such 
as PD. This phenomenon is termed excitotoxicity (Lynch and Guttmann 2001). 
The PSD is enriched in multiple synaptic proteins that transduce glutamatergic 
signals and are responsible for normal synaptic connectivity (Figure 2; Sheng and 
Hoogenraad 2007). Knockout of one or more of these synaptic proteins can lead to 
changes in normal synaptic function and connectivity, including loss of long-term 
potentiation (LTP) or long-term depression (LTD), molecular correlates of learning and 
memory (Malenka and Bear 2004). In short, LTP serves as a sort of ‘synaptic 
strengthening’ following stimulus (Bliss and Collingridge 1993) while LTD is the 
selective loss of this synaptic strength (Massey and Bashir 2007). Furthermore, it has 
been postulated that proper conductance of LTD is necessary in spatial memory (Bear 
1999). 
Functional connectivity in the striatum is not only lost in PD patients, but also in 
animal models of PD. For instance, LTD is lost in 6-hydroxydopamine (6-OHDA)-
treated rats, as 6-OHDA eliminates dopaminergic projections to the striatum (Calabresi et 
al. 1992; Ingham et al. 1989). Moreover, dopamine depletion in rodents, non-human 
primates, and human PD patients leads to decreased striatal MSN dendritic spine number, 
a change in dendritic spine shape, and a decrease in the overall length of the dendrites. 
Also seen is a rearrangement of the post-synaptic proteins found in the PSD (Ingham et 
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al. 1993; Villalba et al. 2009; Stephens et al. 2005). While the mechanisms underlying 
loss of dendritic spines have not been fully appreciated, calcium influx via calcium 
channels is suspected to play a critical role (Day et al. 2006). As stated above, calcium 
influx can activate downstream signaling cascades, which play a role in modulating spine 
density and/or morphology. 
As noted in the previous section, one of the major causes of PD is striatal DA 
depletion as a consequence of nigrostriatal neuronal loss (Albin et al. 1989). These 
nigrostriatal neurons synapse on striatal MSNs. These striatal MSNs exist in two distinct 
populations: those that contain dopamine D1 receptors and those that contain dopamine 
D2 receptors (described below; Strange 1993). The D1 family of receptors are GαS -
protein-coupled and activate adenylyl cyclase and downstream PKA signaling. In 
contrast, the D2-family of receptors are Gαi-coupled and inhibit adenylyl cyclase and 
downstream PKA signaling (Stoof and Kebabian 1981). In normal brain function these 
‘direct’ and ‘indirect’ pathways (D1 and D2 pathways, respectively) are balanced, 
resulting in the stimulation of normal movement as well as the inhibition of improper 
movement (Albin et al. 1989; Figure 3; Frank et al. 2004). In PD, this balance is upset, 
resulting in patient’s difficulty conducting voluntary movements (Starr 1995).  
 
1.3 Spinophilin Function and Localization 
It has been shown that Ca2+ is primarily localized to the spines of hippocampal 
neurons (Berridge 2006), suggesting that a major function of spines is to localize calcium 
(Yuste et al. 2000). The presence of Ca2+ is necessary to activate signaling molecules 
 
 
6 
 
such as protein kinases and phosphatases (Kennedy 2000; Sheng and Kim 2002) leading 
to the activation of downstream processes via phosphorylation and/or dephosphorylation. 
Specifically, in PD there is increased phosphorylation and activation of Ca2+/calmodulin-
dependent protein kinase II (CaMKII) (Picconi et al. 2004; Brown et al. 2005). This 
increase in phosphorylation may be due to changes in the activity of the serine/threonine 
protein phosphatase 1 (PP1) (Brown et al. 2005), a highly conserved protein phosphatase 
that has a wide array of functions in eukaryotes (Bollen et al. 2010). Interestingly, 
phosphatase activity is highly promiscuous and is often regulated by specific interacting 
proteins known as regulatory subunits or targeting proteins.  
Spinophilin is a recently discovered protein that was previously thought to be an 
integral part of PP1. In fact, it is so often found colocalized with PP1 that it was 
originally named ‘PP1-binding protein’ (Allen et al. 1997). Spinophilin can target PP1 to 
specific substrates, such as components of the neuronal cytoskeleton (Ragusa et al. 
2010), such as F-actin (Grossman et al. 2004; Terry-Lorenzo et al. 2002) and is essential 
to proper spine structure and function (Allen et al. 1997). However, PP1 activity towards 
certain substrates can be inhibited when tightly bound to spinophilin (Bollen et al. 2010; 
Ragusa et al. 2010). Dopamine depletion leads to a decrease in PP1 activity, which might 
also occur in striatal neurons of human PD sufferers (Brown et al. 2008). Because 
spinophilin binds directly to the catalytic subunit of PP1, it is possible that this change of 
function may be due to improper targeting of the phosphatase in PD (Ragusa et al. 2010). 
Interestingly, the association of PP1 with spinophilin is enhanced in a rat model of PD 
(Brown et al. 2008). 
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Furthermore, it has been shown that spinophilin can associate with CaMKII and 
may be important in targeting the CaMKIIα isoform to F-actin (Baucum et al. 2012; 
Carmody et al. 2008; Terry-Lorenzo et al. 2005). Additionally, the interaction of 
spinophilin with F-actin is modulated by phosphorylation of spinophilin at the N-
terminal, F-actin binding domain (Grossman et al. 2004; Feng et al. 2000; Hsieh-Wilson 
et al. 2003). It is especially important to note that the spinophilin/F-actin interaction has 
been shown to affect synaptic plasticity, spine maturation, and spine maintenance (Feng 
et al. 2000; Nakanishi et al. 1997; Zito et al. 2004) as actin is also enriched in dendritic 
spines (Cingolani and Goda 2008). This is supported by evidence suggesting that 
spinophilin aids in binding F-actin to the cell membrane (Satoh et al. 1998). 
As previously noted, spinophilin has been shown to directly interact with CaMKII 
(Baucum et al. 2012) and is primarily localized within 100nm of the PSD (Muly et al. 
2004). Given its interactions with F-actin, PP1, and CaMKII it is likely that the 
alterations to spinophilin and its interactions with other synaptic proteins is important in 
regulating normal synaptic function and spine morphology. Consistent with this 
hypothesis, spinophilin knockout mice show an increase in spine density at postnatal day 
15 (Feng et al. 2000) and have altered LTD (Allen et al. 1997; Feng et al. 2000). 
Conversely, knockdown of spinophilin in hippocampal cultures leads to decreased 
dendritic spine density (Evans et al., 2015). Moreover, function of synaptic receptors, 
such as AMPARs and NMDARs, by PP1 is due to proper targeting of PP1 by spinophilin 
(Yan et al. 1999; Liu et al. 2006), further implicating the necessity of spinophilin in 
normal brain function. A more recent study utilizing spinophilin knockout mice 
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implicates spinophilin in G protein-coupled receptor (GPCR) sensitivity (Lu et al. 2010), 
demonstrating a role for spinophilin in G-protein signal transduction cascades. 
Proteomics approaches have identified multiple spinophilin interacting proteins in 
mouse striatal tissue (Baucum et al. 2010). Interestingly, multiple intermediate neuronal 
filament (neurofilament) proteins were detected in spinophilin immunoprecipitations 
(IPs). These interactions were specific as no there were no spectral counts matching these 
proteins in IPs from knockout spinophilin tissue (Baucum et al. 2010). From these 
studies, it can be inferred that spinophilin interacts with multiple cytoskeletal proteins 
(i.e. F-actin, neurofilament medium, etc.) in MSN dendrites, potentially playing a role in 
spine formation and dynamics.  
 
1.4 Intermediate Filament Function and Localization 
Neurofilaments are typically comprised of four distinct intermediate filament (IF) 
subunits dubbed neurofilament (NF) light, medium, and heavy, (NF-L, M, and H 
respectively), and α-internexin. NF-L, M, and H were first described in the 1970s as the 
68,000 160,000, and 210,000 Dalton polypeptides, respectively, in studies identifying 
large axonal proteins (Hoffmann and Lasek 1975; Schlaepfer and Freeman 1978). These 
proteins contain three distinct domains; head, rod, and tail and it is believed that the 
highly conserved rod domain is key to proper interactions between NF proteins (Yuan et 
al. 2012; Bocquet et al, 2009). Although NFs are mainly localized to axons, they are also 
present in dendrites and have demonstrated widespread effects in neurodegenerative 
diseases (Yuan et al. 2012), which will be discussed below.  
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Of importance, NF proteins have been proven to be important factors in dendritic 
arborization, implying that proper function of NF proteins is essential for synaptic 
connectivity (Kong et al. 1998). Furthermore, NFs are also major players in axonal 
growth, imparting the appropriate length and radius to axons (Collard et al. 1995). Small 
projections from the tail domain of NF proteins allow for proper spacing and are 
responsible for extending axon radial growth. It is important to note that NF-M has a 
greater effect on radial growth than either NF-L or NF-H (Rao et al. 2003). Overall, 
various studies have shown that the normal expression of NFs is critical to normal 
neuronal structure and function. 
Numerous studies have examined the phosphorylation state of NFs and the effects 
of these modifications. In fact, early studies identified abnormal phosphorylation as the 
cause of structural and functional changes in NF-M and NF-H (Carden et al. 1984). 
Others have shown that an increase in expression of both NF-M and NF-H leads to 
disruption of dendritic arborization, and therefore synaptic connectivity (Kong et al. 
1998). Specifically, improper accumulation or disruption of all three types of IFs are 
characteristic of PD as well as amyotrophic lateral sclerosis (ALS), among other 
neurodegenerative disorders (Al-Chalabi and Miller 2003; Julien 1999).  
Additional data suggest that a high level of NF-M phosphorylation leads to its 
improper aggregation as well as disruption of its interaction with other cytoskeletal 
proteins (Al-Chalabi and Miller 2003; Gou et al. 1998; Trimpin et al. 2004). 
Furthermore, multiple NF-M phosphorylation sites have been identified, many of which 
exist in the C-terminal tail (Betts et al. 1997; Cleverley et al. 1998). Specifically, when 
the tail domain of NF-M is aberrantly phosphorylated, filament assembly, cross-linking, 
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and transport are often disrupted, resulting in the formation of the aforementioned protein 
aggregates. Moreover, it has also been shown that NF proteins exist mainly in an 
unphosphorylated state in the dendrites (Lee et al. 1987; Yuan et al. 2012) suggesting 
that proper dendritic function is dependent, in part, upon proper NF post-translational 
modifications. Interestingly, neurofilament aggregates are sometimes present in 
cytoplasmic inclusions commonly known as Lewy bodies, which are frequently seen in 
PD and other neurodegenerative diseases (Kong et al. 1998; Betts et al. 1997). In 
addition, polymorphisms in NF-M have also been shown to increase the risk of PD 
(Kruger et al. 2003). Together, these data demonstrate that normal NF function and its 
dysfunction are linked to phosphorylation state and that these proteins are altered in PD. 
 
1.5 Neuronal Function of Protein Kinases and Phosphatases 
Phosphorylation status is modulated by protein kinases and phosphatases. In 
eukaryotes, these enzymes are some of the most widely expressed. In fact, it is estimated 
that the human genome contains upwards of 500 kinases (Manning et al., 2002) and 150 
phosphatases (Cohen 2002). Importantly, these proteins regulate and/or modulate a 
plethora of neuronal processes including synaptic plasticity, axon/dendrite formation, and 
others (Soderling 2000).  
Phosphorylation is regulated by a balance between kinase and phosphatase 
activity. Therefore, regulation of kinase or phosphatase activity or localization has 
significant effects on its substrate phosphorylation (Cohen 1992; Meiselbach et al. 2006). 
Interestingly, there are ~385 kinases that have serine/threonine activity (Manning et al., 
2002); however, there are only ~40 serine/threonine phosphatases (Cohen 2002) that 
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balance the activity of these kinases. In order to obtain substrate selectivity, these 
phosphatases associate with specific targeting or regulatory proteins (Janssens et al. 
2008; Cohen 2002; Scott and Pawson 2009). 
Protein phosphatase 1 (PP1) is a serine/threonine phosphatase that is an important 
regulator of synaptic receptor function. In order to obtain specificity, the PP1 catalytic 
subunit associates with >50 targeting or regulatory proteins (Cohen 2002), usually via an 
R-V-x-F-type motif (Ceulemans and Bollen, 2006; Meiselbach et al., 2006). This protein 
phosphatase, which is localized to dendritic spines, directly binds spinophilin and it is 
thought that spinophilin is responsible for PP1 targeting to downstream substrates (Allen 
et al. 1997). It is also believed that PP1 has effects in the down-regulation of AMPARs 
(Yan et al. 1999), one of the most common glutamate receptor types. This same study 
also shows that when PP1 and spinophilin dissociate, AMPARs become 
dephosphorylated, leading to decreases in channel activity. Interestingly, Yan and 
colleagues, among others, suggest that the effects of PP1 on AMPARs are directly 
reversed by a cAMP-dependent protein kinase (protein kinase A; PKA), which will be 
discussed below (Roche et al. 1996). A more recent study has also shown that spinophilin 
can target PP1 to additional substrates such as CaMKII, an important protein kinase. This 
study also demonstrated an age-dependent increase in this targeting (Baucum et al. 2012). 
It is important to note that PP1 activity is also decreased through the activation of 
DARPP-32, a small regulatory protein that is prominent in the CNS. This activation of 
DARPP-32 occurs as a result of phosphorylation via PKA (discussed below; Fienberg et 
al. 1998; Svenningsson et al. 2004). 
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 PKA is highly abundant in the CNS and is one of the most important kinases in 
modulating glutamate receptor phosphorylation (Tingley et al. 1997). Previous studies 
suggest that phosphorylation of these receptors has effects in important neurological 
processes such as LTD and LTP (Raymond et al. 1993; Roche et al. 1994). Additional 
research has shown that PKA activation has a significant effect on neurite formation in 
developing cells (Weisenhorn et al. 2001) and can phosphorylate important structural 
proteins such as NF-M and NF-H (Cleverley et al. 1998; Sihag et al. 1999). Furthermore, 
PKA activity is modulated in rat models of PD and following long-term treatment with L-
DOPA (Oh et al. 1997). 
PKA is one of the most important second-messenger kinases and its activity can be 
modulated through dopamine signaling pathways as noted in section 1.2. As mentioned 
above, activation of D1 receptors increases adenylyl cyclase activity (Stoof and Kebabian 
1984; Sibley and Monsma 1992; Herve et al. 2001). Adenylyl cyclase then cleaves 
phosphate groups from ATP and refolds the molecule to form cAMP. cAMP then binds 
to the regulatory subunit of PKA allowing for the release of the active catalytic subunit 
(PKAc). The indirect pathway is complementary in that dopamine activation of D2-
family of receptors inhibits adenylyl cyclase, resulting in inhibition of PKA (Stoof and 
Kebabian 1984; Sibley and Monsma 1992). It is important to remember that 
dopaminergic neurons synapse on striatal MSNs that also receive excitatory 
glutamatergic inputs. PKA is important in regulating glutamate-dependent activation of 
its receptors (Surmeier et al. 2007). Specifically, glutamate signaling is affected by the 
phosphorylation of glutamate receptors via PKA (Tingley et al. 1997). 
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Cyclin-dependent kinase 5 (Cdk5) is also an important neuronal protein kinase that 
was originally believed to have effects in the cell cycle, but this has since been disproven. 
Furthermore, Cdk5 is a misnomer, as it has been shown to operate independent of cyclin 
(Dhavan and Tsai 2001). However, it has been shown that ablation of Cdk5 expression is 
fatal in mice due to improper formation of the cortex. This activity is specific to tissue of 
the CNS, as formation of various other organs was unaffected (Ohshima et al. 1996). 
Furthermore, there is evidence that suggests Cdk5 is an important regulator of neurite 
growth in newly differentiated cells (Sharma et al. 1999). The aforementioned study by 
Ohshima and colleagues also suggest that improper phosphorylation of IFs by Cdk5 leads 
to accumulation of these proteins in cell bodies due to the disruption of axonal transport. 
Importantly, IF phosphorylation via Cdk5 has been demonstrated using proteins isolated 
from mouse and rat (Shetty et al. 1993). Cdk5 has also been shown to phosphorylate the 
important neuronal protein Tau, leading to its aggregation in Alzheimer’s disease 
(Baumann et al. 1993).  
Moreover, Cdk5 has dynamic affects in dopamine-signaling pathways. It has been 
shown that DARPP-32 inhibits PKA when phosphorylated at a Cdk5 phosphorylation site 
(Bibb et al. 1999). Cdk5 can also phosphorylate protein phosphatase inhibitor 1 which 
will cause the phosphatase to remain in an inactive state. This allows for the maintenance 
of PP1 activity and implicates Cdk5 as an indirect PKA antagonist (Bibb et al. 2001). 
Taken together, these data suggest that proper protein kinase and phosphatase activity, 
and a balance between the two, is necessary for proper synaptic formation, structure and 
function.  
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1.6 Hypotheses 
Taken together, these data suggest that changes in the NF-M/spinophilin 
interactome may modulate dendritic spine morphology and/or maintenance, which could 
in turn alter post-synaptic signaling. Changes in neurofilament-spinophilin interactions 
might also have a significant impact on the overall dendritic structure. The modulation of 
these aforementioned interactions may have implications in a variety of 
neurodegenerative diseases. However, specific protein-protein interactions involving 
important structural proteins, such as neurofilament proteins and spinophilin, have not yet 
been fully characterized. It was our goal to begin elucidating these interactions beginning 
with the aforementioned spinophilin/NF-M interaction. Previous data (presented above; 
Baucum et al. 2010; Table 1) show that NF-M and spinophilin associate specifically in 
striatal lysates. 
Discussed above, there are differences in phosphatase activity in animal models of 
PD. We have also found that both Cdk5 and PKA phosphorylation sites on spinophilin 
become phosphorylated in 6-OHDA lesioned animals (unpublished observations). Taken 
together, these data suggest that a balance of protein-protein interactions and potentially 
downstream kinase and phosphatase activity is essential in maintaining normal synaptic 
connectivity and brain function. Therefore, we hypothesized that the phosphorylation 
state of spinophilin regulates its interactions with the structural protein NF-M. Moreover, 
we hypothesize that alterations in spinophilin associations with NF-M will alter the 
targeting of PP1 and/or CaMKII to NF-M to regulate NF-M phosphorylation.  
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CHAPTER 2. MATERIALS AND METHODS 
2.1 Generating DNA Constructs 
 
2.1.1 PCR 
Full-length spinophilin constructs were amplified using end-point polymerase 
chain reaction (PCR) using a human spinophilin template (a gift from Dr. Maria Vivo, 
University of Naples “Federico II”). The PCR products were ligated into a pDONR221 
vector (Life Technologies, Carlsbad, CA) and subsequently Gateway-cloned into various 
destination vectors for protein expression (see below). For proteins intended to have a C-
terminal tag when expressed, Shine-Kozak sequences were added to each forward primer. 
For proteins intended to have an N-terminal tag, a stop codon was added to each reverse 
primer. Reactions were performed using either Q5 DNA polymerase obtained from New 
England Biolabs (Ipswich, MA) or VAPRase DNA polymerase obtained from Vanderbilt 
University Medical Center (Nashville, TN). Buffers used were specific to each individual 
polymerase. Each reaction was given a 2 minute initial denaturation phase at 98°C. A 30 
second denaturation phase at 98°C followed by a 10 second annealing phase and a 4 
minute extension phase at 72°C were repeated 30 times in standard reactions. Annealing 
phases were run on a gradient with various ranges according to specific melting points of 
oligonucleotides (gradient usually ranged from 60-75°C). A final elongation phase of 12 
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minutes at 72°C was performed. PCR products were mixed with 6x loading dye and 
separated on 1% agarose gels containing SYBR Safe obtained from Life Technologies 
(Carlsbad, CA). Gels were typically run for ~30-40 minutes at 80-90V. The appearance 
of a band of the appropriate size (i.e. 2445 base pairs for full-length spinophilin) 
indicated that the correct sequence had been amplified. These bands were then excised 
from the gel and DNA was isolated using a DNA gel extraction kit (Zymo Research, 
Irvine, CA or ThermoFisher Scientific, Waltham, MA). DNA was typically eluted in TE 
or molecular biology grade deionized water and quantified using the BioTek Cytation 3 
system (BioTek Instruments, Inc. Winooski, VT). Spinophilin fragments containing 
AA1-154, 151-301, and 1-301 were also produced using the techniques outlined above. 
All vectors were sequence verified (GENEWIZ, Inc., South Plainfield, NJ). 
 
2.1.1.1 Mutagenesis PCR 
Mutagenesis reactions were used in order to change either one or two nucleotides 
in a spinophilin sequence encoding amino acids 1-154. Primers were designed using the 
QuikChange site-directed mutagenesis online tool (Agilent Technologies, Santa Clara, 
CA). Reactions were performed using Q5 DNA polymerase along with 50 ng of template 
DNA. Reaction conditions included an initial denaturation of 98°C for 2 minutes. A 45 
second 98°C denaturation, a 1 minute annealing, and a 15 minute elongation at 68°C 
were repeated 18 times before reactions were terminated. 10µL of the reaction mixtures 
were then digested using 1µL of dpn1 for ~2 hours at 37°C. These mixtures were stained 
and separated on a 1% agarose gel. If samples contained the proper banding pattern, 1 µL 
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of the original undigested PCR mixture was used to transform competent E. coli, which 
were cultured as below. Vectors were sequence verified (GENEWIZ, Inc.). Proteins were 
purified from bacteria, as outlined in section 2.2.2.  
Human spinophilin (Uniprot ID: Q96SB3) amino acids 1-154 were aligned with 
amino acid sequences for mouse (Uniprot ID: Q6R891) and rat (Uniprot ID: O35274) 
using Uniprot alignment tool (http://www.uniprot.org/align/; accessed 02/27/2015) in 
order to determine sequence homology (Figure 20).  
 
2.1.2 Gateway BP Cloning 
Following PCR, products were recombined with donor vector (pDONR 221) using 
BP Gateway cloning technology from Life Technologies. 35-50 fmol of PCR product 
was used in each reaction with BP Clonase II enzyme mixture as well as 150 ng of 
plasmid vector. Reactions were performed at 25°C for 4 hours to overnight. Mixtures 
were then treated with proteinase K for 10 minutes at 37°C and 10 µL was used to 
transform DH5α competent E. coli from New England Biolabs. Cells were plated onto 
Luria broth (LB) -agar with kanamycin and incubated overnight at 37°C. Individual 
bacterial colonies were isolated and placed into 5mL liquid LB cultures with kanamycin 
and allowed to incubate overnight at 37°C. 
At the end of the overnight incubation, cells were harvested and lysed. DNA was 
then purified from the lysate using miniprep purification kits from Zymo Research or 
Thermo Scientific. DNA was quantified as described above. 0.5-2 µg of the resulting 
DNA was digested diagnostically using appropriate restriction enzymes and separated on 
a 1% agarose gel before imaging on a Bio-Rad Gel Doc EZ (Bio-Rad Laboratories, Inc. 
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Hercules, CA). If appropriate bands were present, samples were prepared for sequencing 
and mailed to GENEWIZ, Inc. for analysis. Sequence verified samples were used in an 
additional transformation and DNA was purified from LB cultures containing kanamycin. 
50-250 mL cultures were used for either midi or maxiprep purification kits from either 
Zymo Research or Thermo Scientific. Purified DNA was submitted to an additional 
restriction digest in order to confirm the presence of the appropriate insert.  
 
2.1.3 Gateway LR Cloning 
If donor vector products were found to be correct by sequencing and restriction 
digest, DNA inserts were then shuttled into a variety of different destination vectors for 
various uses. Most commonly, the pET-DEST42 and pDEST15 vectors were used for 
His- and GST-tagged protein expression in E. coli, respectively. For mammalian protein 
expression, pcDNA3.1 vectors with either V5, myc, or HA tags were used. Additionally, 
pcDNA-pDEST40 was used for expression of V5-His-tagged proteins in mammalian 
cells. LR reactions were performed using 150ng of template DNA (typically donor vector 
containing desired insert) at 25°C for 1 hour. Proteinase K digestion followed the LR 
reaction at 37°C for 10 minutes. Competent DH5α E. coli were transformed using 1-5 µL 
of the reaction mixture and grown on LB plates in the presence of ampicillin at 37°C.  
Bacterial colonies were plucked after overnight growth and grown in 5mL liquid 
LB cultures with ampicillin for an additional night. DNA was extracted as described 
above and screened via restriction digest. If appropriate DNA banding patterns were 
present, purified DNA was used to transform additional cells. These cells were used in 
larger (50-250 mL) cultures for either midi or maxipreps from Zymo Research or Thermo 
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Scientific. DNA was again screened via restriction digestion. All original empty DNA 
vectors used in BP or LR cloning were obtained from Life Technologies. 
 
2.2 Bacterial Protein Expression 
 
2.2.1 Cell Culture 
Following restriction verification, competent Rosetta pLysS or BL21 cells were 
transformed using up to 1 µL of purified DNA. Bacteria were grown on LB agar plates 
overnight in the presence of ampicillin. Individual bacterial colonies were isolated after 
overnight incubation and placed into 5mL LB cultures for approximately 8 hours to 
overnight. 5 mL cultures were then poured into 250-500mL aliquots of liquid LB with 
ampicillin at 37°C. After ~2 hours of incubation, optical density levels were measured at 
an absorbance of 600nm (OD600). Once OD600 levels reached ~0.6 - 0.8, 1 M isopropyl β-
D-1-thiogalactopyranoside (IPTG; Life Technologies Carlsbad, CA) was added to the 
culture (1 mL/L) in order to induce protein expression. Bacteria were induced and 
cultured at 37°C for ~4 hours or at 16°C overnight.  
 
2.2.2 Glutathione S-transferase-tagged Protein Purification 
Bacteria were pelleted at 4000 x g for 20 minutes and resuspended in lysis buffer 
(50 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.5 mM PMSF, 1 mM benzamidine, 5 mM 
EDTA, 0.5% Triton X-100, 1.0 g/L lysosome, 0.5x protease inhibitor cocktail). Bacterial 
suspensions were sonicated (30 second pulse, 55 second rest at 40% amplitude eight 
times; Model 505 Sonic Dismembrator, Thermo Fisher Scientific, Waltham, MA) at 4°C 
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and centrifuged (12000 x g for 25 minutes at 4°C). The resulting supernatant was then 
incubated with glutathione agarose beads previously washed in lysis buffer for ~1h at 
4°C. Beads were collected on a filter column and washed multiple times in wash buffer 
(50 mM Tris-HCl pH7.5, 200 mM NaCl, 50 µM PMSF, 0.1 mM benzamidine, 0.1 mM 
EDTA, 0.5% Triton X-100) before proteins were eluted in 3mL 20mM glutathione (pH 
8.0). Eluate was placed into Slide-A-Lyzer cassettes and dialyzed in storage buffer (10 
mM HEPES pH 7.5, 25 µM PMSF, 62.5 µM benzamidine, 62.5 µM EDTA, 0.1% Triton 
X-100) for two hours with rotation at 4°C. Storage buffer was then exchanged and 
samples were dialyzed overnight at 4°C. Finally, the eluate was removed from the 
cassettes via syringe and proteins were quantified using the Cytation 3. For 
quantifications, 5 µL of purified protein was added to 2mL Bradford reagent (Bio-Rad 
Laboratories, Hercules, CA) in a cuvette. Samples were incubated at room temperature 
for ~5 minutes. Raw data was quantified using GraphPad Prism. Samples were stored at -
80°C for long-term storage or at -20°C for more immediate use.  
 
2.3 Mammalian Protein Expression 
For mammalian protein expression, human embryonic kidney (HEK293) or mouse 
Neuro2a cells were used. Cells were stored long-term in liquid nitrogen and thawed at 
37°C when needed. Neuro2a cells were incubated with Eagle’s minimum essential 
medium (EMEM). HEK293 cells were incubated in Dulbecco’s modified Eagle’s 
medium (DMEM). Both media contained 10% FBS, L-glutamine, and 
penicillin/streptomycin. 50mm Corning or Nunc culture flasks were incubated at a 
constant 37°C and 5% CO2 (Panasonic Healthcare; Secaucus, NJ).  
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Cells were counted and approximately 250,000 cells were plated into 25 mm flat-
bottomed culture flasks and grown overnight. Cells were transfected at ~60-80% 
confluence. Confluence was measured by examining the approximate cell coverage on 
the bottom of the flask. Typically, 2 µg of each DNA was used in each transfection. The 
appropriate volume of DNA was added to 250 µL of serum-free medium in a 1.7mL 
microcentrifuge tube. In a separate tube, Lipofectamine (Life Technologies) or PolyJet 
reagent (SignaGen Laboratories Rockville, MD) was added to an additional 250 µL of 
medium. Lipofectamine was added in a 3:1 volume:mass ratio (e.g. 18 µL of 
Lipofectamine was used alongside 6 µg DNA). All transfections were performed using 
equal masses of DNA. If necessary, an empty DNA vector was used to normalize DNA 
concentrations across conditions. The two mixtures were then placed in a third tube and 
incubated at room temperature for 15-20 minutes. The entire mixture was then added to 
the appropriate flask and cells were incubated overnight.  
After overnight growth, cells were examined to ensure adherence to flask bottoms. 
If there was little to no disruption of adherence of the cells, the medium was aspirated 
and cells were washed with 8mL cold phosphate-buffered saline (PBS). The wash was 
aspirated and cells were resuspended in 2 mL low ionic Tris-HCl pH 7.4 buffer + Triton 
X-100 buffer before transfer into 2 mL microcentrifuge tubes. If a large number of cells 
had become unattached, they were resuspended in medium and transferred to 15 mL 
centrifuged tubes and centrifuged at 250 x g for 5 minutes. Medium was aspirated and 
cold PBS was used to wash the cells before an additional centrifugation. PBS was then 
aspirated and cells were resuspended in low ionic Tris HCl buffer + Triton X-100 lysis 
buffer (10 mM DTT, 5 mM EDTA, 2 mM Tris-HCl pH 7.5, 1% (v/v) Triton X-100, 20 
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mM NaF, 20 mM β-glycerophosphate, 20 mM NaVO3, 10 mM Na pyrophosphate, 1% 
Halt protease inhibitor cocktail; Thermo Scientific Waltham, MA). Cells were sonicated 
at 4°C for 15 seconds at a 25% amplitude and centrifuged (4°C for 10 minutes at 14,000 
x g). Cell lysates were then used in glutathione S-transferase (GST) pulldowns or 
immunoprecipitations as described in the following sections.  
 
2.4 Tissue Homogenization 
Male or female, WT, C57Bl6 mouse brains were dissected. Forebrain or striatal 
tissue was flash-frozen in liquid nitrogen and stored at -80°C for later use. Tissue was 
homogenized in 2mL of either low ionic Tris-HCl or isotonic KCl buffer containing 1% 
Triton X-100 buffer using twenty up-and-down movements of a pestle in a 2 mL tight-
fitting glass homogenizer. Tissue was then transferred to a 2 mL microcentrifuge tube 
and processed in the same manner as HEK293 cells described above. Striatal tissue 
remained in 2 mL total volume of buffer while cortical tissue was brought up to 5 mL 
using the appropriate buffer. IPs or GST pulldowns were then performed as described 
below. 
 
2.5 Immunoprecipitations 
400µL of HEK293 cell lysate or brain homogenate was transferred to a 1.7 mL 
tube and incubated with the appropriate primary antibody at 4°C for approximately 1 
hour with rotation. Primary antibodies used for immunoprecipitations were a goat 
polyclonal anti-HA tag (A190-107A, Bethyl Laboratories, Inc. Montgomery, TX) or goat 
polyclonal anti-V5 tag (A190-119A, Bethyl Laboratories, Inc.) Additionally, 75 µL of 
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each sample was collected to serve as a non-immunoprecipitated input. 25µL of 4X 
sample buffer (40% glycerol, 0.2 M Tris HCl pH 6.8, 8% SDS w/v, 0.1 M DTT, 0.04% 
bromophenol blue w/v in water) was added to each input and stored at -20°C. At the end 
of the 1-hour incubation, 30 µL of protein G magnetic beads was added to each sample. 
Incubation with protein G beads continued overnight at 4°C with rotation. 
Protein G beads were magnetically separated and washed three times with 
immunoprecipitation buffer (150 mM NaCl, 50 mM Tris HCl, 0.5% Triton X-100). 80 
µL of 2x sample buffer (4x buffer diluted 1:2 with Milli-Q water) was added to each of 
the samples.  
 
2.6 GST Pulldowns 
GST pulldowns were performed using 5µg purified GST-tagged protein. Proteins 
were incubated with 400µL HEK293 cell lysate, homogenized brain lysate, or 5 µg of 
non-GST tagged, purified protein. Total volumes were brought up to 500 µL with GST 
pulldown buffer (200 mM NaCl, 50 mM Tris, 0.5% Triton X-100 in water). Samples 
were incubated for 1 hour at 4°C with rotation. 75 µL of each sample was collected to 
serve as an input, 25 µL 4X sample buffer was added to each input and stored at -20°C. 
30 µL of pre-washed glutathione agarose beads (Thermo Scientific) was then added to 
each sample and incubated overnight at 4°C. After overnight incubation, samples were 
centrifuged at 2000 x g for 1 minute to pellet glutathione agarose beads and any bound 
proteins. The supernatant was aspirated and discarded. Beads were washed three times 
with GST pulldown buffer aspirating the buffer each time. 80 µL of 2X sample buffer 
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was added to each sample and mixed gently by inversion. Samples were heated at 70ºC 
for 10 minutes for SDS-PAGE and western blot analysis (see below).  
 
2.7 SDS-PAGE and Western Blotting 
Western blots were performed using samples obtained from GST pulldown or IP 
assays described above. IP samples were placed on a magnet before sample loading in 
order to pull magnetic beads out of suspension. Glutathione agarose beads were pelleted 
through centrifugation at 2000 x g for 1 minute before sample loading. 10 µL of each 
input along with 20 µL of each sample was loaded onto either a 1.0 mm or 1.5 mm hand-
cast 10% polyacrylamide gels or onto a 26-well, pre-cast Criterion 4-15% or 4-20% 
gradient gel (Bio-Rad). Gels were typically run at 75 V for 15 minutes and 175 V for 
approximately 1 hour or until sample buffer dye front had run off of the gel. Proteins 
were then transferred to nitrocellulose membranes using one of two methods.  
For high molecular weight protein analysis (over ~100kD), a wet transfer was 
used. Gels were placed inside a sandwich containing two rectangular filter papers as well 
as the nitrocellulose membrane. The sandwiches were placed into a transfer unit 
containing N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) transfer buffer (10% 
MeOH, 0.01 M CAPS pH 11). The transfer unit was attached to a water chilling unit set 
to 2.5-4°C. Protein transfers were run at a constant 1.0 A for 90 minutes.  
For proteins with low molecular weights (below ~100kD), the Bio-Rad Trans-Blot 
Turbo was used. Filter paper stacks and pre-cut membranes were equilibrated in cold 
transfer buffer for 3-5 minutes. Excess buffer was poured off and stacks were placed in a 
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transfer cassette with membrane beneath the gel. Transfer stacks were then rolled in order 
to remove excess bubbles. Transfers were then run at a constant 1.3 A for 30 minutes.  
After transferring, membranes were trimmed and placed in incubation boxes. An 
optional Ponceau stain was often used to visualize protein transfer. Membranes were then 
washed with deionized water and scanned. Membranes were then blocked using 5% 
(w/v) nonfat dry milk in 0.1% (v/v) Tween 20 in 1 M tris-buffered saline pH 7.5 (TBST). 
Blocking was done 3x for 10-20 minutes. The final blocking solution was discarded and 
the membranes were incubated with primary antibodies (1:2000 dilution in 5% milk) 
overnight at 4°C with shaking. Primary antibodies used were: a goat polyclonal anti-
neurabin-II (sc-14774; Santa Cruz Biotechnology, Inc. Dallas, TX), a mouse monoclonal 
anti-NF-M (#2838 Cell Signaling, Danvers, MA), a goat polyclonal anti-PP1γ (sc-6108 
Santa Cruz Biotechnology), a mouse monoclonal anti-PKA C-α (#5842 Cell Signaling), 
or a goat polyclonal anti-GST (A190-121A Bethyl Laboratories, Inc.). Excess antibody 
was then discarded and membranes were washed 3-5 times with 5% milk for 5-10 
minutes each wash. Appropriate secondary antibodies were conjugated to alexafluor 680 
or 790 nm (1:10000 dilution in 5% milk) for approximately 45-60 minutes at room 
temperature in darkness with shaking. Secondary antibodies were discarded and 
membranes were washed three times with 0.1% TBST for 5-10 minutes and two times in 
TBS for 5-10 minutes. Fluorescence scans were obtained using the Li-Cor Odyssey and 
data were analyzed using Image Studio software (LiCor). Relative quantifications were 
calculated based on total amount of GST protein present in each sample. 
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2.8 Pro-Q Diamond in-gel Staining 
Following SDS-PAGE, gels were stained for phosphorylated proteins. Gels were 
fixed using 50% MeOH/10% acetic acid in water twice for thirty minutes. Fixative was 
then removed and gels were washed three times for ~10 minutes with deionized water. 
Pro-Q Diamond staining solution from Invitrogen (ThermoFisher Scientific, Waltham, 
MA) was then added and incubated for ~60 minutes. Stain was removed and gels were 
de-stained with 20% acetonitrile, 50 mM sodium acetate in water pH 4 three times for 
~30 minutes each. Finally gels were washed twice for ~5 minutes with deionized water 
and visualized using the Bio-Rad Gel Doc. 
 
2.9 In-vitro Kinase Activation 
To activate endogenous PKA in HEK293 cells, 5 mM 3-isobutyl-1-methylxanthine 
(IBMX) and 500 µM forskolin in DMSO were used. Cells were transfected as described 
above and incubated overnight. Medium was removed and replaced with DMEM 
containing IBMX and forskolin (1:1000 dilution). Cells were then incubated for 30 
minutes to overnight at 37°C. At the end of incubation, flasks were immediately placed 
on ice and cells were processed as described above. 
 
2.10 In-vitro Protein Phosphorylation 
Active PKA (New England Biolabs, Ipswich, MA) was used to phosphorylate 
purified proteins in vitro. 50 nM PKA was used in solution with 1x NEBuffer (New 
England Biolabs), and 0.2 mM ATP. Volumes of GST-fused proteins were added to each 
reaction mixture to yield a 2 µM purified protein concentration in a total volume of 50 µL 
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(Q.S. with molecular biology-grade water). Separate reaction mixtures with 30mM 
EDTA without ATP were created to serve as mock phosphorylation controls. Reactions 
were incubated at 30°C for 20 minutes. 3 µL of 0.5 M EDTA was added to each mixture 
after incubation in order to halt kinase activity. 50 µL of each reaction mixture was 
incubated with 400µL of brain tissue or HEK cell homogenate along with 50 µL of GST 
pulldown buffer. GST pulldowns were then completed as described in section 2.5. 
Additionally, 5 µg His-tagged NF-M was similarly phosphorylated via PKA in vitro and 
incubated with homogenized brain lysate as described above. Pulldowns were performed 
using Talon resin beads via the process described in section 2.5 and immunoblotted as 
described in section 2.7.  
 
2.11 Mass Spectrometry 
Samples separated by SDS-PAGE were digested with trypsin and analyzed by mass 
spectrometry. Specifically, samples were processed at the Vanderbilt University Mass 
Spectrometry Research Center, in the Indiana School of Medicine Core Facility, or in the 
laboratory of Dr. Lisa Jones, using an LTQ Orbitrap Velos, Velos Pro, or QExactive mass 
spectrometer (Thermo Fisher Scientific Waltham, MA), respectively. Raw data files were 
converted to MzXML files using MassMatrix Mass Spec Data File Conversion Tool (Xu 
and Freitas, 2009). MzXML files were searched against the NCBI Reference Sequence 
human or mouse database using MS-GF+ (Kim et al., 2010) or against the Uniprot 
database using MyriMatch (Tabb et al., 2007). Searched files were assembled in either 
Scaffold 4 (Proteome Software, Portland, OR) or IDPicker (Holman et al., 2012). 
Spectral counts matching spinophilin-associated proteins were derived from these 
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assembled files. Tryptic fragments containing phosphorylated sites were further evaluated 
by measuring the area under the curve (AUC) of the extracted ion chromatogram (XIC) 
that matched a specific phospho-peptide. These areas were normalized to either the non-
phosphorylated peptide or to a control peptide to generate a ratio of phosphorylation. 
These ratios were compared across different groups, as previously described (Baucum et 
al., 2015). 
 
2.12 Statistical Analyses 
Western blots from immunoprecipitations were quantified using Image Studio 
software. Integrated densities for the co-immunoprecipitating protein were divided by the 
integrated density in the corresponding input and of the corresponding 
immunoprecipitated protein. All values obtained from Western blots are presented in 
relative units. Western blots from GST pulldowns were quantified by dividing the 
integrated density of the associated protein by the integrated density of the corresponding 
GST protein. For statistical analyses, values were normalized to a control group and 
compared using an unpaired t test (two groups) or one-way ANOVA (more than two 
groups).  
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CHAPTER 3. RESULTS 
3.1 Validation of the Interaction between Spinophilin and Neurofilament Medium 
Recent mass-spectrometry-based data have shown that spinophilin and NF-M co-
immunoprecipitate from striatal lysates (Baucum et al. 2010). To further examine and 
validate this interaction, we immunoprecipitated spinophilin and NF-M from cortical 
lysates of C57Bl/6 mice. Tissue was homogenized in a Triton X-100 and KCl-containing 
buffer with protease and phosphatase inhibitors (see methods) in order to maintain an 
isotonic condition and prevent protein degradation and dephosphorylation. Western blots 
of NF-M and spinophilin immunoprecipitations from cortical tissue demonstrate 
reciprocal association between NF-M and spinophilin (Fig. 4). Reciprocal 
immunoprecipitations also produce these results in striatal tissue (not shown). 
Furthermore, immunoprecipitations using an anti-PP1 antibody isolated both NF-M and 
spinophilin, suggesting that all three proteins may exist in the same complex (Fig. 4). 
This interaction was specific as a control IgG did not precipitate spinophilin, NF-M, or 
PP1.  
 
3.2 Neurofilament Medium Interacts with Spinophilin Residues 1-154 and 1-301 
In order to determine the spinophilin motif that interacts most strongly with NF-M, 
GST pulldowns in brain homogenate as well as cell lysates from HEK293 cells were 
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utilized. Brain homogenates were incubated with GST-fused spinophilin fragments 
containing amino acids 1-154, 151-301, or 1-301 as the neurofilament protein, NF-L, has 
been previously shown to interact with the N-terminus of spinophilin (Baucum et al. 
2012). Samples were submitted to SDS-PAGE and Western blots were performed using 
an antibody for NF-M. Qualitative data show strong NF-M pulldown when incubated 
with fragments containing AA 1-154 and 1-301 (Fig. 5). Similar pulldowns were also 
performed from HEK293 cell lysates wherein a V5-tagged NF-M was overexpressed. 
Qualitative data from these experiments support the observation that NF-M binds to 
spinophilin fragments containing AA1-154 and AA1-301 (data not shown).  
 
3.3 PP1 Increases the Interaction between Spinophilin and Neurofilament Medium 
To further validate the association of spinophilin and NF-M, we utilized a 
heterologous cell system, HEK293 cells, to overexpress spinophilin and NF-M. HEK293 
cells overexpressing NF-M (V5-tagged) and spinophilin (HA tagged) were separated by 
SDS-PAGE and immnoblotted for NF-M and spinophilin. Consistent with results in 
tissue lysates, both proteins co-immunoprecipitated in HEK293 cells (Fig. 6A). Given 
that PP1 co-immunoprecipitates with spinophilin and NF-M in cortical lysates, we 
wanted to further validate that these proteins also interact in HEK293 cells. Moreover, 
previous data generated in the lab suggest that spinophilin phosphorylation and 
association with NF-M are increased and decreased, respectively, in an animal model of 
PD (Fig. 18). Therefore, we wanted to determine if PP1 activity modulates the 
association of these two proteins. We expressed a GFP-tagged PP1 (Carmody et al. 2008) 
in the presence of spinophilin and/or NF-M. Reciprocal IPs were performed using 
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antibodies for either the HA or the V5 protein tag and were analyzed by Western blot. 
Results revealed that addition of PP1 enhanced the association of NF-M and spinophilin 
by approximately 2-fold (Fig. 6B). This increased association may be due to a molecule 
of spinophilin and a molecule of NF-M binding the same catalytic subunit of PP1. 
However, it has been previously shown that PP1 does not directly bind to NF-M. 
However, it can bind to NF-L (Terry-Lorenzo et al. 2000). This is consistent with the fact 
that NF-M IPs contain PP1 (Fig 6A) even in the absence of spinophilin. Moreover, NF-L 
binding of PP1 may target spinophilin to the neurofilament complex; however, this is 
unlikely given many PP1-binding proteins associate via the same R-V-X-F motif (Egloff 
et al. 1997). Therefore, an alternative hypothesis is that overexpression of PP1 decreases 
phosphorylation of spinophilin and/or NF-M and that this phosphorylation may modulate 
the association. To further test this, we evaluated the effect of phosphorylation on 
modulating the spinophilin/NF-M interaction (discussed below). 
 
3.4 PKA Phosphorylates Spinophilin and NF-M 
Both spinophilin and NF-M are phosphorylated by multiple kinases (See 
introduction). Consistent with these data, in-gel phosphorylation-specific protein staining 
(Pro-Q Diamond) shows an increase in spinophilin (Fig 7A) and NF-M (data not shown) 
phosphorylation when both V5-tagged NF-M and HA-tagged spinophilin were 
transfected in the presence of overexpressed PKA (Fig. 7A). Pro-Q Diamond-stained gels 
were stained using Imperial Protein Stain. Appropriate bands were excised from the gel 
and sent for MS/MS analysis (Fig. 7B). Preliminary MS/MS data are consistent with the 
ProQ staining, showing increased phosphorylation of spinophilin and NF-M. Specifically, 
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spinophilin phosphorylation was increased at Ser100, Ser116, Ser126, and Ser203 (Fig 
7C) and NF-M phosphorylation was increased at Ser346 and Ser736 (Fig 7D).  
 
3.5 PKA and Phosphorylation-Dependent Modulation of the Interaction between 
Spinophilin and Neurofilament Medium  
 
3.5.1 In Vitro Phosphorylation of Spinophilin Fragments Decreases Association with 
Multiple Proteins, Including NF-M. 
Spinophilin fragments containing AA1-154 and AA1-301 were incubated with the 
purified catalytic subunit of PKA (PKAc) in the presence or absence of ATP 
(phosphorylated and mock samples, respectively). GST alone was used as a control. 
EDTA was then used to halt catalytic activity at the end of the incubation period. Mock-
treated or autophosphorylated fragments were incubated with mouse cortical lysate and 
precipitated by glutathione agarose, separated by SDS-PAGE, and either Coomassie 
stained or immunoblotted for NF-M.  
Interestingly, mock treated samples show a strong, non-significant increase in NF-
M levels when compared to purified protein controls. This pattern is seen in samples 
containing spinophilin AA1-154 as well as 1-301 (Fig. 8A). However, when PKAc is 
active, NF-M signal returns to control levels. Despite consistency in these patterns, they 
contain a high level of variability (Fig. 8B; 8C). In addition to associations with NF-M, 
spinophilin phosphorylation by PKA decreased the intensity (Imperial stain) of many 
spinophilin-associated proteins (SpAPs) isolated from spinophilin GST-pulldowns using 
N-terminal spinophilin fragments (Fig. 9). These samples were extracted and analyzed by 
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MS/MS. These data reveal that spectral counts matching NF-M were lower in the 
phosphorylated compared to non-phosphorylated forms (Table 2).  
Conversely, full-length His-tagged NF-M was phosphorylated in vitro via PKA 
and incubated with homogenized brain lysate. Talon resin beads were used to bind and 
pull His-tagged proteins out of suspension. Samples were then separated via SDS-PAGE 
and immunoblotted for spinophilin. Data reveal that PKAc, per se, enhanced the 
association of spinophilin and NF-M in the absence of ATP. There is a slightly weaker 
increase in samples where ATP is present. These patterns are consistent but non-
significant, as there is a high level of variability (Fig. 10B). 
 
3.5.2 Point Mutations in Spinophilin Fragments Decrease NF-M in Spinophilin 
Pulldowns  
In order to determine the role of specific phosphorylation sites on spinophilin in 
modulating its association with NF-M, GST-tagged spinophilin constructs containing 
amino acids 1-154 containing point mutations at serine 17 and/or 100 were created. 
Specifically, serines were mutated to either an aspartic acid (to mimic phosphorylation) 
or alanine (to prevent phosphorylation). These sites were selected due to Ser17 and 
Ser100 being hyper-phosphorylated in a mouse model of PD (Fig. 11). Additionally, both 
residues were mutated to either alanine or aspartic acid. GST alone, WT or mutant 
spinophilin fragments containing amino acids 1-154 were incubated with cortical tissue 
homogenized in KCl-containing buffer. Both individual single point mutants and a 
double alanine mutant were highly variable (individual experiments might show either an 
increase in association or a decrease in association; data not shown). However, mutating 
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both Ser17 and Ser100 to aspartic acid consistently and significantly decreased the 
amount of NF-M in the spinophilin pulldowns (Fig. 12).  
Sequence alignment revealed that residues Ser17 and Ser100 are conserved among 
human, rat, and mouse spinophilin sequences. Furthermore, amino acids 1-154 show a 
high level of sequence similarity among all three species (Fig. 13). 
 
3.5.3 Short-term Activation of Endogenous PKA Attenuates the Interaction between 
Spinophilin and NF-M 
IBMX and forskolin were used to pharmacologically activate endogenously 
expressed PKA in HEK293 cells. V5-tagged NF-M and HA-tagged spinophilin were 
transfected alone or together and cells were incubated with IBMX/forskolin in DMSO to 
activate PKA or in DMSO alone. Samples were immunoprecipitated for either HA or V5 
and Western blots for NF-M and spinophilin were performed (Fig. 14A). Quantified data 
show a significant decrease in levels of NF-M in HA IPs as well as a decrease in levels of 
spinophilin in V5 IPs when normalized to non-immunoprecipitated inputs (Fig. 14B). 
Appropriate bands were excised and prepared for MS/MS analysis (Fig. 15). Preliminary 
data suggest that there is no difference in the levels of spinophilin phosphorylation upon 
short-term activation. However, phosphorylation of NF-M increases at several sites. 
Specifically, Ser736 and Ser837 have an ~1.5 fold increase or greater in PKA-dependent 
phosphorylation. NF-M has multiple repeat sequences that are phosphorylated. 
Specifically, Ser620 and Ser685 are on indistinguishable fragments following tryptic 
digestion. Interestingly, this tryptic fragment as well as a tryptic fragment phosphorylated 
at Ser615 and Ser620 had a 2-3-fold increase in phosphorylation. Moreover, a second 
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repeat sequence (with phosphorylation sites at Ser633, Ser646, and Ser659) also had 
PKA-dependent increases in phosphorylation. Moreover, the doubly phosphorylated 
peptide (with phosphorylation at Ser628 and Ser633, Ser641 and Ser646, and/or Ser654 
and Ser659) was also increased by short-term PKA activation. Interestingly, when 
spinophilin is overexpressed with NF-M in samples where PKA has been activated, 
phosphorylation was attenuated all of these increases in phosphorylation (Fig. 16). These 
studies are currently being validated. 
 
3.5.4 Long-Term Activation of Endogenous PKA in HEK293 Cells Enhances the 
Interaction between NF-M and Spinophilin 
In addition to short-term activation experiments, IBMX and forskolin were used to 
activate endogenous PKA in HEK293 cells over a period of 16-20 hours. Cells were 
transfected and treated as in section 3.5.1. Surprisingly, there was a slight but significant 
increase in the level of spinophilin in NF-M IPs (Fig. 17). Gels were also Imperial stained 
and bands were excised for MS/MS analysis (Fig. 18). These data also reveal that the 
level of spinophilin phosphorylation is unchanged. We also analyzed levels of NF-M 
phosphorylation in the presence or absence of spinophilin following overnight PKA 
activation. Preliminary results suggest that overnight activation increased 
phosphorylation ~2-fold at the Ser620/685 site. Interestingly, this increased 
phosphorylation was attenuated by co-expression of spinophilin (Fig 19). Additional sites 
are also shown with variable phosphorylation. It is important to note that MS/MS data 
presented herein were produced from single experiments. Further replicates will need to 
be conducted in the future. 
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3.5.5 Overexpression of PKA in HEK293 Cells Increases NF-M in Spinophilin IPs 
Given that purified, inactive PKA enhanced the association of spinophilin with 
NF-M in the GST pull-down studies and that long-term activation of PKA resulted in a 
slight, but significant increase in the spinophilin/NF-M interaction, we wanted to 
determine the effect of overexpressing PKAc on modulating the spinophilin/NF-M 
association in a heterologous cell system. V5-tagged NF-M and HA-tagged spinophilin 
were co-expressed in HEK293 cells alone or alongside myc-tagged PKA. Lysates were 
immunoprecipitated for either the HA (spinophilin) or the V5 (NF-M) tag. IPs were 
blotted for NF-M or spinophilin. Qualitatively, there was a robust increase in the 
association between spinophilin and NF-M in the presence of PKA (Fig. 20A). When 
analyzed quantitatively, this increase is shown to be approximately 20-fold (Fig. 20B). 
Western blots performed using an antibody for PKA also indicate that the kinase co-
immunoprecipitates with both spinophilin and NF-M (Fig. 20A).  
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CHAPTER 4. DISCUSSION 
4.1 Spinophilin Interacts with NF-M  
Data previously produced have shown a specific interaction between spinophilin 
and NF-M in mouse brain homogenate when spinophilin knockout and wild type tissues 
are analyzed via MS/MS (Baucum et al. 2010). Here, we immunoprecipitated spinophilin 
or NF-M from brain lysates or transfected HEK293 cells. In order to maintain an isotonic 
environment similar to conditions in the brain, brain lysate experiments were performed 
using an isotonic KCl-containing buffer. We found that both NF-M and PP1 co-
immunoprecipitate with spinophilin. Moreover, spinophilin and NF-M co-
immunoprecipitate with PP1. Interestingly, NF-M IPs do not consistently precipitate 
spinophilin. This may be due to the NF-M antibody binding the same motif as 
spinophilin, higher background associated with the NF-M antibody, or differences in the 
stoichiometries of associations. For instance, spinophilin binding to a single NF-M 
molecule may pull down multiple NF-M monomers, whereas NF-M binding to 
spinophilin would be predicted to pull down at most two homomeric spinophilin 
molecules. As spinophilin has already been shown to specifically interact with PP1 
(Grossman et al. 2004; Terry-Lorenzo et al. 2002), PP1 may bridge the apparent 
interaction between spinophilin and NF-M, as opposed to a direct interaction between 
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these two proteins. However, this is not likely given that PP1 tends to bind at an R-V-x-F 
motif in a single regulatory subunit (Egloff et al. 1997). Furthermore, it has been shown 
that NF-M and PP1 do not directly interact (Terry-Lorenzo et al. 2000), further 
suggesting that spinophilin may target PP1 to NF-M. In addition to spinophilin, NF-L 
binds to PP1 and may target it to NF-M. Consistent with this, PP1 co-precipitated with 
NF-M in transfected HEK293 cells even in the absence of overexpressed spinophilin. 
This may be due to NF-L binding both PP1 and NF-M. However, spinophilin and NF-L 
may target PP1 to different phosphorylation sites on NF-M. Future studies will need to 
determine functional differences between spinophilin and NF-L targeting of PP1 to NF-
M.  
Additional pull-down assays have been used in order to further elucidate the nature 
of the interaction between NF-M and spinophilin. NF-L was previously shown to pull-
down with the N-terminus of spinophilin (Baucum et al. 2012). This finding prompted 
the production of spinophilin fragments containing amino acids 1-154, 151-301, and 1-
301 containing a GST tag to determine if a similar region associated with NF-M. Brain 
tissue was again homogenized in KCl-containing buffer and incubated with these GST-
fused proteins. Samples were then incubated with glutathione agarose beads, which binds 
to GST and can be easily removed from suspension through centrifugation (Guan and 
Dixon 1991). Samples were submitted to SDS-PAGE and western blots were performed 
using antibodies for NF-M and GST. Data were normalized to the amount of GST-fused 
protein (spinophilin). Results reveal that NF-M binds strongly to both the AA1-154 and 
binds very poorly to the fragment containing AA151-301. Also, NF-M associates with 
these same two fragments when V5-tagged NF-M was transfected into HEK293 cells. 
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Taken together, these data demonstrate specific association between the N-terminal 
region of spinophilin and NF-M in multiple systems and under various conditions.  
 
4.2 PP1 Enhances the Interaction between NF-M and Spinophilin 
In order to determine the effects of PP1 on the interaction between spinophilin and 
NF-M, overexpression experiments in HEK293 cells were performed. Spinophilin and 
NF-M were expressed with HA and V5 tags as above, respectively in the presence or 
absence of GFP-fused PP1. Spinophilin has been previously shown to target PP1 to 
specific substrates (Ragusa et al. 2010; Allen et al. 1997). Furthermore, 6-OHDA 
lesioned mice show an increase in spinophilin phosphorylation along with a decrease in 
the association between NF-M and spinophilin. Therefore, we hypothesized that 
enhanced phosphorylation may contribute to this decreased association and that 
overexpressing a phosphatase would enhance the interaction between spinophilin and 
NF-M. As expected, there is an increase in the levels of NF-M in spinophilin IPs where 
PP1 has also been overexpressed. As mentioned above, NF-L and spinophilin may both 
be targeting PP1 to NF-M. Moreover, they may modulate different sites. Interestingly, 
this targeting may be important in maintaining the typically low levels of basal NF-M 
phosphorylation (Lee et al. 1987; Yuan et al. 2012). From these results, we infer that NF-
M and spinophilin naturally interact in mouse neuronal tissue. However, the nature of this 
interaction (i.e. direct interaction of spinophilin and NF-M, or the association of 
protein(s) that can bridge this interaction) is not entirely clear. However given that PP1 
and NF-M do not directly interact (Terry-Lorenzo et al. 2000) and that it is unlikely that 
PP1 would be bridging an interaction, it is unlikely that PP1 is responsible for directly 
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bridging these proteins. We predict that PP1 is acting to decrease the phosphorylation 
status of spinophilin and/or NF-M and lower levels of phosphorylation are linked to an 
increase in the association of these proteins.  
The phosphatase/kinase balance has proven necessary for many essential cellular 
functions, including cell division (Meraldi and Nigg 2001). More specifically, it is critical 
in keeping phosphorylation levels of NF-M low (Roche et al. 1996). In a rat model of PD 
there is an increase in the association with spinophilin and PP1 (Brown et al. 2008). This 
may lead to improper targeting or loss of phosphatase function (Bollen et al. 2010; 
Ragusa et al. 2010). Improper phosphatase function may result in downstream 
consequences, such as protein aggregation or altered cellular structure. Given that 
dendritically-localized NFs normally have low phosphorylation levels (Yuan et al. 2012), 
mechanisms that modulate NF phosphorylation may lead to improper NF localization 
and/or aggregation. Taken together, our data demonstrate a PP1-dependent modulation of 
the spinophilin/NF-M interaction and suggest that phosphorylation status is a critical 
regulator of the spinophilin/NF-M association. Alterations in this association may allow 
for regulation of PP1 targeting to NF-M by spinophilin. Future studies need to address 
the functional effects of this altered targeting. 
 
4.3 PKA Activation Affects the Interaction between NF-M and Spinophilin 
Given our hypothesis that phosphorylation per se modulates the spinophilin/NF-M 
association and that overexpression of PP1 increases this association, we next began 
evaluating the effects of a kinase on regulating the spinophilin/NF-M association. PKA 
has been shown in previous studies to phosphorylate spinophilin (Hsieh-Wilson et al. 
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2003). In order to examine the consequences of increased phosphorylation on the 
interaction between NF-M and spinophilin, endogenous PKA in HEK293 cells was 
activated through the use of IBMX, a phosphodiesterase inhibitor (Corbin and Francis 
2001) and forskolin, an adenylyl cyclase activator (Seamon and Daly 1980). Data 
previously obtained suggest that there is a decrease in the interaction between spinophilin 
and NF-M in a mouse model of PD (Fig. 11). In accordance with these findings, a 
reduction in the level of NF-M in spinophilin IPs was found when endogenous PKA was 
activated over a short time course (30 minutes). The same was found when levels of 
spinophilin in NF-M IPs were examined. Unexpectedly, there was no change in the level 
of spinophilin phosphorylation after PKA activation at the known PKA site, Ser100 as 
analyzed by mass spectrometry. However, there was an increase in the level of NF-M 
phosphorylation under these conditions. 
Conversely, long-term activation of PKA (16-20 hours) increases the NF-
M/spinophilin interaction. These unexpected data suggest that PKA may be playing 
multiple roles in regulating the interaction between NF-M and spinophilin. It is possible 
that the different time courses of activation leads to NF-M phosphorylation at different 
sites or that long-term pharmacological treatment leads to compensatory changes. A more 
recent study has used computer models to predict PKA phosphorylation sites on 
spinophilin including serines 87, 94, 99, 100, 122, and 126 (Xue et al. 2005). 
Interestingly, similar to the short-term activation study outlined above, there was no 
increase in spinophilin phosphorylation upon long-term endogenous PKA activation, at 
least at the known PKA site, Ser100. It is possible that additional sites on spinophilin 
tryptic peptides that were not detected in our analysis are being hyper-phosphorylated. 
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Future studies will need to further analyze spinophilin phosphorylation upon PKA-
dependent activation under both long-term and short-term activation conditions. 
Interestingly, MS/MS data indicate various changes in the phosphorylation state of 
NF-M at specific serine residues. Therefore, changes in NF-M phosphorylation may be 
modulating the association between spinophilin and NF-M. Interestingly, there appears to 
be fairly striking differences in an initial proteomics screen evaluating the 
phosphorylation status of NF-M under short-term compared to long-term activation. 
Specifically, phosphorylation of multiple residues on NF-M increased or remained at 
control levels in samples where a short-term PKA activation took place 
We observed increased phosphorylation of spinophilin at Ser100 in an animal 
model of PD. However, it is unclear the mechanisms that are linked to this altered 
phosphorylation. One putative, spinophilin-dependent mechanism may involve 
modulation of spinophilin with various G-protein-coupled receptors (GPCRs). 
Spinophilin has been shown to associate with the dopamine D2 receptor and the α2A 
adrenergic receptor (Smith et al. 1999; Wang and Limbird 2002). Furthermore, it has 
been shown that spinophilin knockout can enhance coupling of GPCRs to their G-
proteins and can modulate the actions of arrestins to modulate GPCR levels (Wang et al., 
2004; Lu et al. 2010). The association of spinophilin with the dopamine D2 receptor, may 
position this molecule in close proximity to the D2 receptor and to downstream adenylyl 
cyclase and PKA. Given that PD is associated with loss of dopamine and disinhibition of 
adenylyl cyclase, we hypothesize that this may be one mechanism by which spinophilin 
is hyper-phosphorylated at the Ser100 site. Future studies will need to specifically test 
this hypothesis. 
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4.4 In Vitro Phosphorylation via PKA Reduces the Interaction between NF-M and 
Spinophilin 
To determine if spinophilin phosphorylation by PKA directly regulates its 
association with NF-M, we phosphorylated GST-tagged spinophilin fragments with the 
catalytic subunit of PKA (PKAc) and incubated phosphorylated and mock treated 
fragments with cortical tissue homogenates. Cortical lysates was also incubated with GST 
fragments in the absence of PKA. We precipitated the GST proteins, separated SpAPs via 
SDS-PAGE, and evaluated total SpAPs in the phosphorylated and mock conditions. 
Interestingly, there was an overall decrease in the relative amount of SpAPs associated 
with the phosphorylated N-terminal GST-spinophilin fragment. MS/MS data confirm this 
observation and suggest that phosphorylation of spinophilin via PKA is responsible for 
attenuating the interaction between spinophilin and a swath of structural proteins (Table 
2). While we have begun to validate these changes with NF-M, future studies will need to 
evaluate some of the other proteins (e.g. myosins) that also appear to be regulated by 
spinophilin phosphorylation. 
 
4.5 Mutation of Specific Amino Acid Residues Reduces the Interaction between NF-M 
and Spinophilin 
As was previously discussed, PKA phosphorylates spinophilin at Ser100 (Hsieh-
Wilson et al. 2003). Additionally, Cdk5 phosphorylates spinophilin at Ser17 (Futter et al. 
2005). In order to examine the specific effects of phosphorylation at these sites, GST-
tagged spinophilin mutants were generated containing amino acid residues 1-154. 
Fragments containing Ser17Ala, Ser17Asp, Ser100Ala, or Ser100Asp mutations as well 
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as Ser17/100Ala and Ser17/100Asp were produced. As was expected based on previous 
data, fragments where both residues were mutated to aspartic acid (phosphorylation-
mimicking; Bornancin and Parker 1997) decreased the interaction between spinophilin 
and NF-M. Taken together, these data suggest that phosphorylation of spinophilin at both 
Ser17 and Ser100 via Cdk5 and PKA, respectively, will reduce the interaction between 
NF-M and spinophilin.  
However, single mutants, regardless of which mutation or site, yielded variable 
results. In addition, double mutants containing alanine (an amino acid that cannot be 
phosphorylated; Bornancin and Parker 1997) at both Ser17 and Ser100 would be 
expected to increase the level of NF-M in spinophilin pull-downs, as we have seen that 
absence of phosphorylation enhances the interaction between spinophilin and NF-M (as 
discussed in section 3.5.1). However, this double mutation (Ser17/100Ala) also produced 
variable results and actually trended towards a decrease in association. A likely 
explanation is that because of this fragment’s small size, the changing of two amino acids 
may lead to protein misfolding and decrease the association with NF-M. Continuation of 
these types of experiments will require the implementation of more robust methods. 
Further studies wherein full-length spinophilin has been mutated may also be useful in 
order to further validate these findings.  
Also of importance is the increase in spinophilin phosphorylation at Ser17 and 
Ser100 in 6-OHDA lesioned mice (Fig. 18). However, the experiments described in this 
section only take into account human spinophilin fragments while simultaneously 
utilizing cortical tissue obtained from mice. Therefore, it was necessary to verify 
sequence similarity among species. As Uniprot sequence alignment revealed, both Ser17 
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and Ser100 are conserved among mouse, rat, and human (Fig. 20), implying that the 
aforementioned phosphorylation events in animal models might also occur in human PD 
patients. 
 
4.6 Overexpression of PKA Enhances the Interaction between NF-M and Spinophilin 
We showed that short-term and long-term activation of PKA led to decreased and 
increased association between spinophilin and NF-M, respectively. While these 
differences may be due to differences in phosphorylation of NF-M (see above) an 
alternative hypothesis is that long-term activation leads to greater levels of free PKAc. To 
test the effect of enhanced free PKAc, we overexpressed spinophilin and/or NF-M in the 
absence or presence of a myc-tagged PKAc. Interestingly, overexpression of PKAc 
caused a very robust increase in the association of NF-M and spinophilin. As discussed 
above, this increased association might be due to substantively greater or different 
phosphorylation in the presence of a high abundance of PKAc. In spinophilin IPs where 
PKA was also overexpressed, several phosphorylation sites were detected via MS/MS. 
Specifically, we found that there was greater phosphorylation of spinophilin at Ser100, 
Ser116, Ser126, and Ser203. Interestingly, two PKA phosphorylation sites (Ser100 and 
126; Hsieh-Wilson et al. 2003) were detected in the absence of overexpressed PKA, 
suggesting some endogenous low-level of kinase activity; however, phosphorylation of 
both of these sites increased upon PKA overexpression. Of the additional sites that 
become phosphorylated when PKA is overexpressed, many of them are actually predicted 
Cdk5 phosphorylation sites (Xue et al. 2005). These data diverge from data found when 
activating PKA, where no change in spinophilin phosphorylation was seen. In addition to 
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spinophilin, NF-M phosphorylation at Ser346 and Ser736 was higher upon 
overexpression of PKA. Both of these sites were increased following short-term 
activation of PKA in HEK293 cells, albeit to much lower extents. However while the 
Ser346 site is slightly increased following long-term activation, the Ser736 site was 
actually decreased. 
While phosphorylation of spinophilin at sites such as Ser116 and Ser203 in 
HEK293 cells in the presence of high levels of PKA may be the cause of the increased 
association between spinophilin and NF-M in these conditions, another possible 
mechanism would be PKAc bridging the interaction between spinophilin and NF-M. 
Interestingly, PKAc was observed in both NF-M and spinophilin immunoprecipitates. 
Therefore, overexpression of PKA may result in enhanced bridging between the two 
proteins. Moreover, long-term kinase activity may lead to either greater PKAc levels 
and/or different NF-M phosphorylation states compared to the short-term activation.  
To test if bridging per se can modulate the association between spinophilin and 
NF-M, we incubated purified spinophilin with purified PKAc in the absence or presence 
of ATP. Interestingly, there was an overall increase in the association of NF-M and 
spinophilin when PKAc is present but inactive (due to absence of ATP and EDTA) 
versus samples where PKAc is absent. Qualitative data indicate a very low association of 
NF-M and spinophilin in the absence of PKAc when samples were analyzed via Western 
blot. In samples where PKAc is active, this association remains similar. Taken together, 
these data suggest that the catalytic subunit of PKA, is bridging the interaction between 
NF-M and spinophilin when inactive. This is somewhat surprising as the amount of 
PKAc used in these in vitro phosphorylation experiments is extremely low. Further 
 
 
47 
 
studies will need to examine the effects of PKA in this context. Furthermore, there was a 
trend for an increase in the association of NF-M with spinophilin when NF-M was pre-
incubated with active or non-active PKAc. Taken together, our data suggest that increases 
in the spinophilin/NF-M association may be due to a bridging effect of free PKAc rather 
than PKAc activity. However, PKAc activity may attenuate the ability of the catalytic 
subunit to bind to spinophilin. To our knowledge, these exciting data are the first to show 
a bridging role for inactive PKA. It is unclear if PKAc is sufficient to bridge the 
interaction between spinophilin and NF-M or if additional protein(s) are involved. 
 
4.7 Functional Implications in Spinophilin/NF-M association 
Interestingly, when spinophilin was co-expressed with NF-M, there was an 
increase in the phosphorylation of NF-M at Ser30. While PKA activation per se did not 
modulate phosphorylation at this site, the spinophilin-dependent increase in 
phosphorylation at this site was attenuated by both short-term and long-term activation of 
PKA. It is unclear why spinophilin increases NF-M phosphorylation at this site in the 
absence of PKA. Interestingly, in addition to PP1, spinophilin has been shown to 
associate with CaMKII (Baucum et al., 2012). It is possible that spinophilin is targeting 
CaMKII or another kinase to NF-M to regulate its phosphorylation. Moreover, upon PKA 
activation, the association between spinophilin and NF-M is attenuated as is the increased 
NF-M phosphorylation at this site. Interestingly, multiple other sites on NF-M were 
increased by PKA phosphorylation. These include peptides containing Ser346, 615, 620, 
633, 641, 646, 654, 657, 659, 680, 685, 736, and 837. Given the repeat structure of NF-
M, phosphorylation is detected on two identical peptides and therefore may be occurring 
 
 
48 
 
at multiple sites on NF-M. While PKA increased phosphorylation at these peptides, 
spinophilin normalized the phosphorylation at some of these sites. This suggests a 
functional role of spinophilin in modulating the phosphorylation of NF-M by spinophilin.  
In contrast to the short-term phosphorylation, long-term PKA activation had 
variable effects on different residues, including both increasing and decreasing 
phosphorylation. Interestingly, phosphorylation of the tryptic peptide containing Ser620 
and Ser685 was increased by overnight expression of PKA and this phosphorylation was 
attenuated by co-expression of spinophilin. One possible explanation for these data is that 
spinophilin is targeting PP1 to NF-M to modulate specific residues. While these data are 
preliminary, they are very exciting as they suggest a functional role for spinophilin in 
modulating NF-M phosphorylation. 
 
4.8 Summary 
Data presented here suggest that the interaction between spinophilin and NF-M is 
regulated by phosphorylation as well as PP1 and PKA expression. Specifically, 
dephosphorylation via PP1, phosphorylation via PKA (and potentially Cdk5), and 
expression of PKA modulate this interaction. First, we verified that spinophilin and NF-
M interact in brain tissue lysates as well as when both proteins are overexpressed in 
heterologous cell lines. We also established that PP1 increases the interaction between 
spinophilin and NF-M. PP1 has been shown to coimmunoprecipitate with both 
spinophilin and NF-M, suggesting that all three may exist in the same complex.  
 We have also found that phosphorylation via PKA attenuates the interaction 
between spinophilin and NF-M under certain conditions. Specifically, PKA-dependent 
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phosphorylation of spinophilin fragments reduces binding of these fragments to NF-M 
when compared to mock-transfected controls. Furthermore, a short-term activation of 
endogenous PKA in HEK293 cells decreases the level of NF-M in spinophilin IPs. Point 
mutations that mimic phosphorylation of spinophilin at one PKA site and one Cdk5 site 
also indicate a decrease in the association of NF-M and spinophilin. However, when 
long-term activation of PKA is conducted and when PKAc is overexpressed in this same 
cell system, there is a significant increase in the association between NF-M and 
spinophilin. Taken together, these data suggest the existence of two different mechanisms 
by which the NF-M/spinophilin interaction can be regulated. 
The functional implications in modulating the spinophilin/NF-M interaction are 
unclear. It is possible that low levels of PKA activity or free PKAc may attenuate the 
spinophilin/NF-M association in order to maintain the phosphorylation of NF-M at higher 
levels. Conversely, very high levels of PKAc may be triggering a greater association of 
spinophilin with NF-M in order to enhance the targeting of PP1 to NF-M to balance out 
very high PKA activity.  
 
4.9 Conclusion and Future Directions 
PD is characterized by the loss of nigrostriatal dopaminergic neurons. Dopamine 
depletion in the striatum may disinhibit PKA activation in dopamine D2 receptor-
containing neurons, enhancing PKA activity in this class of MSNs. At the molecular 
level, there is a rearrangement of the various proteins that reside in the dendritic spines of 
postsynaptic cells. As suggested by an animal model of PD, two such proteins whose 
interactions change are spinophilin and NF-M. It is possible that the proper localization 
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of NF-M by spinophilin is necessary for the proper formation/structure and function of 
dendritic spines. Attenuation of the association of NF-M and spinophilin may lead to 
perturbations in spine structure and function. 
Our data suggest that PKAc bridges the association between spinophilin and NF-
M. To further test this, we plan to purify a ‘kinase dead’ mutant, wherein a specific 
amino acid residue has been mutated in order to ablate catalytic activity of the kinase. 
This will aid in further evaluating the bridging function of PKAc and that this bridging 
occurs independent of catalytic activity.  
Interestingly, mutation of Ser17 and Ser100 to aspartate leads to attenuation of the 
spinophilin/NF-M association. Given that Ser17 is a CDK5 site, future studies will need 
to evaluate the role of CDK5-dependent phosphorylation on regulating the 
spinophilin/NF-M interaction. This could be done by phosphorylating purified 
spinophilin constructs or by expressing low levels of the Cdk5 activator p25 or p35 (Tang 
et al. 1995) in HEK293 cells.  
Additionally, further studies utilizing animal models of PD could be useful in 
assessing increases and/or decreases in either kinase or phosphatase levels and/or activity. 
These experiments could also examine differences in spinophilin’s interaction with 
additional IF proteins (i.e. NF-H, etc.) that can affect dendritic spine structure. Additional 
animal studies might include producing mutants where expression of either spinophilin or 
NF-M has been knocked out. Whereas NFs have been suggested to affect formation of 
spines (Lee et al. 1987; Yuan et al. 2012), they have not yet been studied in this context. 
We would expect that knockout of single NF protein expression would severely disrupt 
the formation of spines as well as axons, and therefore, synaptic connectivity. 
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Immunohistochemical imaging studies using confocal microscopy with tissue extracted 
from both wild type and mutant animals could help elucidate further questions pertaining 
to the colocalization of the various proteins discussed herein. These studies could also be 
conducted in HEK293 cells where spinophilin, NF-M and PP1 or PKA are 
overexpressed. 
We have specifically explored the differences in the interaction between NF-M and 
spinophilin due to changes made to spinophilin (outside of in vitro phosphorylation of 
full-length NF-M). Future studies might consider some complimentary experiments. For 
example, identifying the NF-M motif (head, rod, or tail) that specifically interacts with 
spinophilin will be useful in evaluating the differences in this interaction. Once this has 
been established, it will be easier to manipulate NF-M and to determine which, if any, 
alterations to this protein will affect its association with spinophilin.  
Overall, the data presented herein reveal important changes in the interaction 
between two important neuronal proteins. Furthermore, it seems that phosphorylation via 
PKA as well as its potential bridging effects, have a significant effect on spinophilin’s 
ability to associate with NF-M. The detriment or benefit of these changes has not yet 
been explored and will require additional studies. It is possible that a decrease in the 
interaction between NF-M and spinophilin is one of the underlying causes of some of the 
morphological and behavioral changes observed in PD.  
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Figure 1: Tripartite system effected in PD. Excitatory glutamatergic neuron projects 
from the cortex to synapse on the heads of dendritic spines that protrude from striatal 
MSNs. Dopaminergic neurons project from the substantia nigra to synapse on the neck 
of dendritic spines. Dopaminergic neurons are lost in PD. 
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Figure 2: PSD structure. Multiple classes of synaptic proteins interact in a 
coordinated fashion in order to transduce the signal from the presynaptic 
glutamatergic neurons. These proteins are critical for normal spine maintenance, 
signal transduction, and function. Figure adapted from Sheng and Hoogenraad, 
2007. 
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Figure 3: Normal circuitry of the basal ganglia. PD is characterized by the loss of 
dopaminergic neurons projecting from the substantia nigra (SNc) to the striatum (Frank et 
al. 2004). 
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Figure 4: NF-M coimmunoprecipitates with spinophilin and PP1 in cortex. 
Immunoprecipitations performed using mouse cortical tissue homogenized in a KCl-
containing buffer. Immunoprecipitates were blotted using antibodies raised against 
spinophilin (upper panel), NF-M (middle panel), or PP1 (lower panel). 
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Figure 5: NF-M interacts with spinophilin fragments containing residues 1-154 and 
1-301. Cortical lysates were incubated with GST spinophilin fragments. Precipitates were 
blotted with an NF-M antibody. NF-M associates most strongly with fragments 
containing spinophilin amino acid residues 1-154 and 1-301. 
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Figure 6: PP1 increases the association of spinophilin and NF-M. A) Western blot of 
HEK 293 cells transfected with V5-tagged NF-M, HA-tagged spinophilin, and/or PP1γ1. 
HEK-cell lysates were blotted for antibodies directed against spinophilin, NF-M, and PP1 
(left). Immunoprecipitations were performed with rabbit monoclonal antibodies for HA 
or V5 (right; as noted). Immunoprecipitates were blotted with antibodies for spinophilin, 
NF-M, and PP1. B) Quantified data showing a relative increase in the amount of NF-M in 
spinophilin IPs when PP1 is co-transfected. p < 0.001. n = 5. 
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Figure 7: PKA enhances spinophilin phosphorylation. A) HEK 293 cells were 
transfected as indicated. Immunoprecipitations were performed with antibodies for the 
HA tag (spinophilin) and samples were separated by SDS-PAGE then stained with Pro-Q 
Diamond. B) Subsequently, gels were post-stained with Imperial stain. C) 
Phosphorylation percentage at specific spinophilin residues in the absence (-) or presence 
(+) of PKA. D) Phosphorylation percentage at specific NF-M residues in the absence (-) 
or presence (+) of PKA when both proteins are overexpressed. Samples were 
immunoprecipitated for NF-M. 
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Figure 8: In vitro phosphorylation decreases spinophilin fragment association with 
NF-M. A) Spinophilin fragments were incubated with the catalytic subunit of PKA in the 
presence (phos.) or absence (mock phos.) of ATP. EDTA was added to each reaction 
mixture after incubation in order to halt catalytic activity. Spinophilin fragments alone or 
mock or phosphorylated fragments were incubated with mouse cortical lysates. GST pull-
downs were blotted with an NF-M specific antibody. B) Quantified data show no 
significant change in under either condition when lysate was incubated with AA1-154. n 
= 5; p = 0.1307. C) Quantified data show no significant change in under either condition 
when lysate was incubated with AA1-301. n = 5; p = 0.0999. 
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Figure 9: In vitro phosphorylation decreases spinophilin’s association with various 
SpAPs. Spinophilin fragments were incubated with the catalytic subunit of PKA in the 
presence (phos.) or absence (mock phos.) of ATP. EDTA was added to each reaction 
mixture after incubation in order to halt catalytic activity. Mixtures were then incubated 
with mouse cortical lysate. GST pulldowns were performed and samples were submitted 
to SDS-PAGE before Imperial protein staining. Various band regions were excised and 
analyzed via MS/MS. 
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Figure 10: In vitro phosphorylation via PKA modulates the interaction between NF-
M and spinophilin. A) NF-M was incubated with PKAc followed by mouse cortical 
lysate. His pull-downs were performed from lysate using Talon resin beads and samples 
were immunoblotted for spinophilin. B) Spinophilin fluorescence data were normalized 
back to the amount of NF-M in each sample. n = 4; p = 0.0672.  
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Figure 11: Phosphorylation at spinophilin Ser17 and Ser100 increases in an animal 
model of PD. A) Coomassie-stained gel showing bands that were excised for MS/MS 
analysis. B) Quantified data showing an increase in phosphorylation events in 6-OHDA 
lesioned tissue vs. intact tissue. 
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Figure 12: Mutating Ser17 and Ser100 to Asp attenuates the interaction between 
NF-M and spinophilin. A) Western blot obtained from GST pulldown experiment where 
mutant spinophilin fragments were incubated with cortical lysate. Immunoblotting was 
performed using antibodies for NF-M and GST. B) Quantified data in arbitrary 
fluorescence units showing a significant decrease in the level of NF-M in GST pulldowns 
when normalized to levels of GST-fused protein. n = 4; p < 0.0001. 
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Figure 13: Spinophilin sequence alignment. Sequence alignment of the first 154 amino 
acids of spinophilin in human (Uniprot ID: Q96SB3), mouse (Uniprot ID: Q6R891), and 
rat (Uniprot ID: O35274). Ser17 and Ser100 are highlighted in yellow. Differences in 
protein sequences are highlighted in green (http://www.uniprot.org/align/). 
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Figure 14: Short-term activation of endogenous PKA decreases the association of 
NF-M and spinophilin. A) Spinophilin and NF-M were transfected in HEK293 cells and 
PKA was endogenously activated. IPs were performed with antibodies directed against 
either the HA or V5 tag and immunoprecipitates were western blotted with antibodies 
directed against either spinophilin or NF-M. B) Quantified data show a decrease in the 
association between spinophilin and NF-M following PKA activation. p < 0.05. n = 3. 
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Figure 15: Short-term PKA activation Imperial stain. HEK 293 cells were transfected 
and endogenous PKA was activated as in Fig. 11. Samples were submitted to SDS-PAGE 
and Imperial stained. Outlined bands were excised and prepared for analysis via MS/MS. 
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Figure 16: Phosphorylation levels of specific serines in NF-M after short-term 
activation. HEK293 cells were transfected with either NF-M, spinophilin, or both. Cells 
that were activated underwent a 30-minute incubation with IBMX and forskolin while 
non-activated samples were incubated with DMSO (vehicle). Samples were separated by 
SDS-PAGE and analyzed via MS/MS.  
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Figure 17: Long-term PKA activation increases the interaction between NF-M and 
spinophilin. A) NF-M and spinophilin were overexpressed in HEK293 cells. IBMX and 
forskolin were used to activate endogenous PKA over 16-20 hours. B) Quanitified data 
reveal increased levels of spinophilin in NF-M IPs when PKA has been activated. n = 4, 
p = 0.0123.  
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Figure 18: Long-term PKA activation Imperial stain. HEK 293 cells were transfected 
and endogenous PKA was activated as in Fig. 16. Samples were subjected to SDS-PAGE 
and Imperial stained. Outlined bands were excised and prepared for analysis via MS/MS. 
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Figure 19: Phosphorylation levels of specific serines in NF-M after long-term 
activation. HEK293 cells were transfected with either NF-M, spinophilin, or both. Cells 
that were activated underwent a 16-20 hour incubation with IBMX and forskolin while 
non-activated samples were incubated with DMSO (vehicle). Samples were separated by 
SDS-PAGE and analyzed via MS/MS.  
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Figure 20: Overexpression of PKA in HEK293 cells enhances the association of NF-
M and spinophilin. A) Western blot showing the increase in association between NF-M 
and spinophilin when PKA is overexpressed. Immunoprecipitations were conducted 
using antibodies for the HA (spinophilin) and V5 (NF-M) tags. Western blots were 
obtained using antibodies for spinophilin, NF-M, and PKA (top to bottom, respectively). 
B) Quantified immunoreactivity show a significant, ~20-fold, increased association 
between spinophilin and NF-M in the presence of PKA. p = 0.004, n = 5. 
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Table 1. Spectral counts of specific neuronal proteins in wild type vs. knockout tissue 
when immunoprecipitated samples are analyzed via MS/MS. 
 Goat IP Rabbit IP 
Protein Spectra WT (KO) Spectra WT (KO) 
Neurofilament Light 4 (0) 19 (0) 
Neurofilament Medium 2 (0) 8 (0) 
α-internexin 5 (0) 14 (0) 
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Table 2. Spectral counts of spinophilin-associated proteins in samples where spinophilin 
fragment AA1-301 has been incubated with PKAc in the absence of ATP (mock) versus 
those incubated with PKAc in the presence of ATP (phosphorylated.   
Protein Mock Phosphorylated 
Myosin-10 224 40 
Myosin-Va 188 22 
Spectrin 79 41 
Myosin-14 29 3 
NF-M 5 2 
NF-H 5 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
